Stabilization of N-Myc Is a Critical Function of Aurora A in Human Neuroblastoma

被引:463
作者
Otto, Tobias [5 ]
Horn, Sebastian [5 ]
Brockmann, Markus [5 ]
Eilers, Ursula [5 ]
Schuettrumpf, Lars [5 ]
Popov, Nikita [5 ]
Kenney, Anna Marie [1 ]
Schulte, Johannes H. [2 ]
Beijersbergen, Roderick [3 ]
Christiansen, Holger [4 ]
Berwanger, Bernd [4 ]
Eilers, Martin [5 ]
机构
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Univ Hosp Essen, Dept Pediat Hematol Oncol & Endocrinol, D-45122 Essen, Germany
[3] Netherlands Canc Ctr, NL-1066 CX Amsterdam, Netherlands
[4] Univ Marburg, Childrens Hosp, Med Ctr, D-35043 Marburg, Germany
[5] Inst Mol Biol & Tumor Res, D-35037 Marburg, Germany
关键词
UBIQUITIN LIGASE; CENTROSOME AMPLIFICATION; DEPENDENT DEGRADATION; PROTEIN STABILITY; TUMOR-FORMATION; HUMAN-CELLS; KINASE-A; CYCLIN-E; C-MYC; PHOSPHORYLATION;
D O I
10.1016/j.ccr.2008.12.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In human neuroblastoma, amplification of the MYCN gene predicts poor prognosis and resistance to therapy. In a shRNA screen of genes that are highly expressed in MYCN-amplified tumors, we have identified AURKA as a gene that is required for the growth of MYCN-amplified neuroblastoma cells but largely dispensable for cells lacking amplified MYCN. Aurora A has a critical function in regulating turnover of the N-Myc protein. Degradation of N-Myc; requires sequential phosphorylation by cyclin B/Cdk1 and Gsk3. N-Myc is therefore degraded during mitosis in response to low levels of PI3-kinase activity. Aurora A interacts with both N-Myc and the SCFFbxw7 ubiquitinates ligase that ubiquitinates N-Myc and counteracts degradation of N-Myc, thereby uncoupling N-Myc stability from growth factor-dependent signals.
引用
收藏
页码:67 / 78
页数:12
相关论文
共 39 条
  • [1] The ubiquitin ligase HectH9 regulates transcriptional activation by myc and is essential for tumor cell proliferation
    Adhikary, S
    Marinoni, F
    Hock, A
    Hulleman, E
    Popov, N
    Beier, R
    Bernard, S
    Quarto, M
    Capra, M
    Goettig, S
    Kogel, U
    Scheffner, M
    Helin, K
    Eilers, M
    [J]. CELL, 2005, 123 (03) : 409 - 421
  • [2] Conditional transgenic models define how MYC initiates and maintains tumorigenesis
    Arvanitis, Constadina
    Felsher, Dean W.
    [J]. SEMINARS IN CANCER BIOLOGY, 2006, 16 (04) : 313 - 317
  • [3] A large-scale RNAi screen in human cells identifies new components of the p53 pathway
    Berns, K
    Hijmans, EM
    Mullenders, J
    Brummelkamp, TR
    Velds, A
    Heimerikx, M
    Kerkhoven, RM
    Madiredjo, M
    Nijkamp, W
    Weigelt, B
    Agami, R
    Ge, W
    Cavet, G
    Linsley, PS
    Beijersbergen, RL
    Bernards, R
    [J]. NATURE, 2004, 428 (6981) : 431 - 437
  • [4] Loss of a FYN-regulated differentiation and growth arrest pathway in advanced stage neuroblastoma
    Berwanger, B
    Hartmann, O
    Bergmann, E
    Bernard, S
    Nielsen, D
    Krause, M
    Kartal, A
    Flynn, D
    Wiedemeyer, R
    Schwab, M
    Schäfer, H
    Christiansen, H
    Eilers, M
    [J]. CANCER CELL, 2002, 2 (05) : 377 - 386
  • [5] A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers
    Bischoff, JR
    Anderson, L
    Zhu, YF
    Mossie, K
    Ng, L
    Souza, B
    Schryver, B
    Flanagan, P
    Clairvoyant, F
    Ginther, C
    Chan, CSM
    Novotny, M
    Slamon, DJ
    Plowman, GD
    [J]. EMBO JOURNAL, 1998, 17 (11) : 3052 - 3065
  • [6] Aurora kinases: New targets for cancer therapy
    Carvajal, Richard D.
    Tse, Archie
    Schwartz, Gary K.
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (23) : 6869 - 6875
  • [7] Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation
    Clurman, BE
    Sheaff, RJ
    Thress, K
    Groudine, M
    Roberts, JM
    [J]. GENES & DEVELOPMENT, 1996, 10 (16) : 1979 - 1990
  • [8] INHIBITION OF GLYCOGEN-SYNTHASE KINASE-3 BY INSULIN-MEDIATED BY PROTEIN-KINASE-B
    CROSS, DAE
    ALESSI, DR
    COHEN, P
    ANDJELKOVICH, M
    HEMMINGS, BA
    [J]. NATURE, 1995, 378 (6559) : 785 - 789
  • [9] Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human
    Ewart-Toland, A
    Briassouli, P
    de Koning, JP
    Mao, JH
    Yuan, JW
    Chan, F
    MacCarthy-Morrogh, L
    Ponder, BAJ
    Nagase, H
    Burn, J
    Ball, S
    Almeida, M
    Linardopoulos, S
    Balmain, A
    [J]. NATURE GENETICS, 2003, 34 (04) : 403 - 412
  • [10] Fbxw7 contributes to tumor suppression by targeting multiple proteins for ubiquitin-dependent degradation
    Fujii, Yo
    Yada, Masayoshi
    Nishiyama, Masaaki
    Kamura, Takumi
    Takahashi, Hidehisa
    Tsunematsu, Ryosuke
    Susaki, Etsuo
    Nakagawa, Tadashi
    Matsumoto, Akinobu
    Nakayama, Keiichi I.
    [J]. CANCER SCIENCE, 2006, 97 (08): : 729 - 736